[go: up one dir, main page]

US20110121033A1 - Skincare Treatment - Google Patents

Skincare Treatment Download PDF

Info

Publication number
US20110121033A1
US20110121033A1 US12/811,705 US81170508A US2011121033A1 US 20110121033 A1 US20110121033 A1 US 20110121033A1 US 81170508 A US81170508 A US 81170508A US 2011121033 A1 US2011121033 A1 US 2011121033A1
Authority
US
United States
Prior art keywords
composition
anhydrous
skin
compositions
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/811,705
Inventor
Rebecca Horne
Diene Kelly
Laurent Kirchhoffer
Richard Koontz
James Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt and Colman Overseas Ltd
Original Assignee
Reckitt and Colman Overseas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Overseas Ltd filed Critical Reckitt and Colman Overseas Ltd
Assigned to RECKITT BENCKISER (UK) LIMITED reassignment RECKITT BENCKISER (UK) LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KOONTZ, RICHARD, KELLY, DIANE, KIRCHHOFFER, LAURENT, YOUNG, JAMES, HORNE, REBECCA
Assigned to RECKITT & COLMAN (OVERSEAS) LIMITED reassignment RECKITT & COLMAN (OVERSEAS) LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RECKITT BENCKISER (UK) LIMITED
Publication of US20110121033A1 publication Critical patent/US20110121033A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24Thermal properties
    • A61K2800/242Exothermic; Self-heating; Heating sensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/31Anhydrous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits

Definitions

  • the present invention relates to a method of treating acne, to an acne treatment kit, to compositions and kits useful in such methods and to processes to prepare said composition and/or kits.
  • Acne vulgaris is a chronic inflammatory condition of the pilosebaceous units of the skin, which is particularly prevalent in adolescents.
  • the condition generally causes the formation, on the skin, of comedones, red papules, pustules and sometimes cysts. This is unsightly and furthermore, if untreated, acne can lead to scarring of the skin.
  • the major causes of acne are thought to be an increase in sebum production, an increased presence of Propionibacterium acne ( P. acne ), blockage of the pilosebaceus duct and the production of inflammation.
  • Remedies for the topical treatment of acne generally provide for the application to the affected area of a skincare composition comprising at least one ingredient effective to treat acne.
  • actives include the classes of topical retinoids, antibiotics, anti-bacterials and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide and salicylic acid.
  • an improved acne treatment may be achieved by the topical administration of an acne active ingredient in the presence of a component that generates heat on the skin.
  • the present invention provides a method of treating acne comprising the topical administration of an acne active ingredient in the presence of
  • the present invention also provides an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.
  • the present invention provides a skincare formulation obtained by mixing on, or prior to application to, the skin comprising
  • anhydrous composition for the treatment of acne comprising an acne active ingredient, a component that in the presence of water generates heat and a carrier therefor.
  • the invention also provides an acne treatment package for dispensing a first and a second composition onto the skin, said first composition being anhydrous and comprising a component that in the presence of water generates heat and said second composition comprising an aqueous component, at least one of said compositions comprising an acne active ingredient, wherein said package comprises a first chamber and a second chamber, each of said first and second chambers having an outlet, wherein said first composition is stored in said first chamber and said second composition is stored in said second chamber, said compositions being stored in isolation from each other and the package being arranged such that said first and second compositions are combined after passing though each respective outlet.
  • the invention also provides a process of dispensing an acne treatment onto the skin comprising the application to the skin of a first composition which is anhydrous and comprises a component that in the presence of water generates heat, and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, and mixing said compositions to generate heat on the skin.
  • the invention also provides a process to prepare an acne treatment kit, comprising inserting a first composition which is anhydrous and comprises a component that in the presence of water generates heat into a first chamber of a multi-chambered package and inserting a second composition which comprises an aqueous carrier into a second chamber of said package, at least one of said compositions comprising an acne active ingredient, and providing means for combining said compositions on, or prior to application to, the skin.
  • anhydrous composition means a composition which is substantially free of water; for example, it will contain less than 2% by weight water preferably less than 1% by weight water and most preferably less than 0.1% by weight water.
  • an acne active ingredient is applied to the skin in the presence of an anhydrous composition comprising a component that in the presence of water generates heat and water.
  • the heat is generated on the skin and is useful to raise the temperature on the surface of the skin.
  • the amount of heat-generating component present in the anhydrous composition is a level that the heat generated by the combination of the anhydrous composition with the water is acceptable on the skin of a user and does not burn the skin.
  • the anhydrous composition may be applied to the skin and water applied thereto.
  • the water may be applied before, at the same time as, or after the application of the anhydrous composition.
  • the anhydrous composition and water are combined by rubbing the ingredients together. In this way the heat generating component is most effectively combined with water to provide a heating effect on the skin.
  • the water may be obtained from any suitable source, for example a water tap.
  • the water may also be provided in an aqueous composition which may include one or more additional ingredients, especially skincare ingredients. There may be sufficient water already present on the skin to produce a suitable heating effect if the anhydrous composition is rubbed into the skin with sufficient vigour.
  • the aqueous composition forms part of a package in combination with the anhydrous composition, which allows a measured amount of water to be applied to the skin thus allowing more control of the heating effect.
  • the administration of the anhydrous composition and the aqueous composition on the skin is substantially simultaneous.
  • the anhydrous composition and aqueous composition may be combined just prior to application to the skin or they may be combined on the skin.
  • the anhydrous composition and aqueous composition may be dispensed from separate chambers within a package. The outlet of each chamber may allow the compositions to be applied directly onto the skin and then combined by the user rubbing the compositions on the surface of the skin or the compositions may be combined as they pass through a dispensing nozzle before application to the skin.
  • a skincare formulation is provided when said anhydrous composition is combined with water. Heat is generated on the skin which enhances the effect of the acne active ingredient.
  • the skincare formulation may be left on the skin in which case the heat generated will gradually subside.
  • the composition is rinsed off the skin, leaving a therapeutically effective amount of the acne active ingredient on the skin.
  • the acne active ingredient may be present separate from the anhydrous composition or the aqueous composition, it may be present in either the anhydrous and aqueous compositions or it may be present in both the anhydrous and aqueous compositions.
  • the acne active ingredient may be selected from any class of materials that are effective to treat acne, including topical retinoids, antibiotics, anti-microbials, anti-bacterials, anti-inflammatory agents and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide, hydrogen peroxide and salicylic acid. If desired two or more acne active ingredients may be employed. The active ingredients may be present in the same or in different compositions.
  • the active ingredient is present in the formulation in a therapeutically effective amount, as generally known in the art. For most active ingredients, a range from 0.001% to 10% by weight, especially from 0.1% to 10% by weight, could be expected. Thus, generally each composition may comprise the above recited amount of acne active ingredient.
  • an acne active ingredient is present in an amount of 0.1% to 5% by weight of the anhydrous composition.
  • an acne active ingredient is present in an amount of 0.1% to 5% by weight of the aqueous composition.
  • an acne active ingredient is present in an amount from 0.1% to 5% by weight of both aqueous and anhydrous compositions.
  • said acne active ingredient is a keratolytic agent such as salicylic acid.
  • Salicylic acid is preferably incorporated into the composition according to the invention as the free acid.
  • the pH of the composition may, and generally will, be such that the salicylic acid exists in the composition in dissociated form.
  • the composition may well contain cationic counterions, the salicylic acid may then be thought of as being present in salt form.
  • the salicylic acid may be incorporated into the composition in salt form, eg as a salt with a Group I metal, such as sodium salicylate.
  • any and all references to salicylic acid should be taken to encompass references to the acid and to dissociated forms and salts thereof.
  • the total concentration of salicylic acid in the formulation according to the invention is preferably at least 0.1% by weight, more preferably at least 0.5% by weight, most preferably at least 1.0% and especially at least 1.5% by weight.
  • the concentration of salicylic acid is preferably less than 10% by weight, more preferably less than 6% by weight, and most preferably less than 4% by weight.
  • the total concentration of salicylic acid may fall in the range 0.1% to 10% by weight, preferably 0.5% to 10% by weight, more preferably 1.0% to 6%, and most preferably 1.5% to 4.0% by weight.
  • a particularly preferred total concentrations of salicylic acid is approximately 1.5-2% by weight of the composition.
  • said acne active ingredient preferably salicylic acid
  • said acne active ingredient is present in the anhydrous and aqueous compositions.
  • the amount of acne active ingredient may be different in each composition.
  • the aqueous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
  • the anhydrous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
  • any pharmaceutically acceptable component that generates heat in the presence of water may be used.
  • Preferred examples are selected from the group of materials that generate heat within the classes of zeolites (aluminosilicates); metal halides, sulphates, carbonates and oxides; and polyhydric alcohols.
  • Preferred classes of materials include zeolites and bivalent metal halides. These materials are well known to those skilled in the art. Examples of bivalent metal halides and oxides may include magnesium chloride, iron chloride, zinc chloride, magnesium oxide, calcium oxide, magnesium sulphate and calcium chloride.
  • Such heat generating materials will suitably be present in the anhydrous composition in an amount to heat the skin to facilitate opening and cleansing of the pores.
  • such materials my be used in an amount of up to 70% by weight of the anhydrous composition, for example, from 1% to 70% by weight, preferably from 1% to 40% by weight, more preferably from 1% to 25% by weight and most preferably from 1% to 15% by weight.
  • the heat generated must be less than that which will cause heat damage to the skin.
  • the temperature of the skin is raised by no more than 50° C.
  • the temperature of the skin is raised by at least 2° C., more preferably at least 10° C.
  • the temperature of the skin may be raised to a temperature in the range 4° C. to 70° C., preferably 4° C. to 15° C.
  • the component that in the presence of water generates heat comprises a bivalent metal halide, further preferably a metal halide selected from magnesium chloride, iron chloride, zinc chloride and calcium chloride, most preferably magnesium chloride.
  • the anhydrous composition comprises from 5% to 60% by weight, preferably from 10% to 50% by weight, more preferably from 12% to 40% by weight and most preferably from 15% to 35% by weight of said water-activatable, heat-generating component.
  • the anhydrous composition comprises an anhydrous carrier.
  • this may be an oily material.
  • a physiologically effective oil useful in accordance with the present invention may be any cosmetically and/or dermatologically acceptable synthetic or natural oil known to the person skilled in the art. Such oils may also provide emollient properties on the skin, for example to maintain the soft, smooth and pliable appearance of the skin.
  • Suitable ingredients include hydrocarbons, silicone oils, triglycerides, waxes, fatty acids, fatty acid alcohols and esters thereof, mineral oils, vegetable oils and hydrogenated vegetable oils, lanolin or mixtures thereof.
  • hydrocarbons examples include paraffins (for example paraffinum liquidum and white soft paraffin), petrolatum, hydrogenated polyisobutene, alkyl benzoates, isohexadecane, isododecane, isononyl isonanoate, diisopropylcyclohexane;
  • silicone oils include dimethicone, cyclomethicone or cetyldimethicone;
  • triglycerides include natural triglycerides and synthetic or semi-synthetic triglycerides;
  • waxes include vegetable waxes such as carnauba wax, animal waxes such as beeswax, and mineral waxes such as paraffin wax, ozokerite;
  • esters of fatty acids or alcohols include isopropyl palmitate, isopropyl myristate, dioctylmaleate, glyceryl oleate and cetostearyl isononanoate, oct
  • Such materials may be used in an amount greater than 30% by weight, more preferably greater than 35% by weight, advantageously greater than 40% by weight and most preferably greater than 45% by weight of the composition.
  • the carrier generally provides the largest component by weight of the anhydrous composition.
  • the anhydrous composition comprises from 30% to 99% by weight, preferably from 35% to 95% by weight, more preferably from 40% to 90% by weight and most preferably from 50% to 85% by weight of said carrier.
  • the anhydrous carrier comprises a mineral oil.
  • the mineral oil is blended with a styrene copolymer, for example a hydrogenated alkylene-styrene copolymer, more preferably a hydrogenated butylene/ethylene/styrene copolymer or a hydrogenated ethylene/propylene/styrene copolymer or a mixture thereof.
  • a particularly preferred source of a mineral oil/styrene copolymer blend is available under the tradename Versagel from Penreco, 138 Petrolia Karns City USA.
  • mineral oil is combined with a hydrogenated alkylene-styrene copolymer/mineral oil blend.
  • the total mineral oil is preferably present in an amount from 50% to 85% by weight, more preferably from 60% to 80% by weight, of the anhydrous composition; conveniently this may be a blend comprising mineral oil in an amount from 25% to 60% by weight (more preferably from 35% to 50% by weight) and a mineral oil/styrene copolymer blend in an amount from 20% to 40% by weight (more preferably from 24% to 32% by weight).
  • the anhydrous composition comprises a surfactant.
  • a surfactant This forms a particularly preferred aspect of the present invention as it provides a composition with advantageous viscosity and skin-feel properties. For example, it may provide a less oily feel to the composition so that it is more pleasant to apply and retain on the skin. For example, a greasy and/or oily and/or sticky feel on the skin may be reduced.
  • the inclusion of a surfactant in a composition where the carrier is a hydrocarbon (such as mineral oil) improves the aesthetic feel of the composition on the skin. In this way, it has been found that less expensive carriers may be employed in the anhydrous composition.
  • the anhydrous composition has good viscosity properties as it is not too viscous to apply and does not run off the skin when applied thereto.
  • a suitable viscosity is that of a thickened liquid such that it is thicker than water and preferably remains in the area to which it is applied, even when the user moves or applies it to a non-horizontal skin surface.
  • the compositions have a viscosity which allow them to be dispensed conveniently from a package, especially through a dispensing nozzle.
  • the viscosity range values of such compositions will be known to those skilled in the art.
  • the inclusion of at least one surfactant may provide that it may not be necessary to include a thickening component in the composition.
  • the anhydrous composition comprises a surfactant and does not include a thickening component.
  • the surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art.
  • non-ionic surfactants include the class of ethoxylated fatty alcohols and other surfactants such as oleth-5, PEG-5 cocamide, polysorbate 20, PEG-40 hydrogenated castor oil, alkyl poly(ethylene oxide), copolymers of poly(ethylene oxide) and poly(propylene oxide) (commercially called Poloxamers or Poloxamines), alkyl polyglucosides, including: octyl glucoside, decyl maltoside, fatty alcohols, cetyl alcohol, oleyl alcohol;
  • anionic surfactants includes the class of alkyl ether sulphates, such as sodium lauryl sulphate, sodium laureth sulphate, sodium dodecyl sul
  • the surfactant comprises an anionic surfactant, optionally in combination with other surfactants.
  • the surfactant comprises an alkali metal sulphate, such as sodium lauryl sulphate and/or sodium dodecyl sulphate.
  • the anhydrous composition comprises from 1-20% by weight surfactant, further preferably from 1% to 10% by weight, more preferably from 3% to 15% by weight and most preferably from 4% to 10% by weight surfactant.
  • the present invention provides an anhydrous composition comprising
  • the anhydrous composition consists essentially of the above ingredients.
  • the aqueous composition is a cleansing composition comprising a surfactant.
  • the surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Particular surfactants may be as described above with respect to the anhydrous composition.
  • the surfactant comprises an anionic surfactant and/or a non-ionic surfactant.
  • Preferred materials include lauryl or laureth sulphates (such as sodium or triethanolamine lauryl/laureth sulphates) and polypropyleneglycols, polyethylene glycols and derivatives thereof.
  • the total surfactant concentration in the aqueous and anhydrous compositions when combined to provide the formulation is sufficient such that when rubbed into the skin, a foam is produced which can be rinsed off the skin.
  • aqueous and anhydrous compositions may also include other skincare ingredients as desired, for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
  • other skincare ingredients for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
  • anhydrous and aqueous compositions may also comprise thickening agents which increase the viscosity of the composition.
  • thickening agents include polyethylene glycols; polyoxyethylene cetyl ethers; Acrylates/Vinyl Isodecanoate crosspolymer, polyamide resins such as Sylvaclear (tradename), lanolin, stearyl alcohol and salt.
  • the present invention provides an aqueous composition comprising
  • the aqueous composition consists essentially of the above ingredients.
  • the anhydrous and/or aqueous compositions comprise from 1-20% by weight thickener, more preferably from 2% to 15% by weight and most preferably from 3% to 10% by weight thickener.
  • aqueous and anhydrous compositions provided in accordance with the present invention are suitably in the form of a liquid or a gel, preferably as a viscous liquid.
  • the anhydrous and aqueous compositions may comprise other conventional ingredients, such as anti-microbial agents, sequestering agents, colouring agents and perfumes.
  • Such ingredients and the amounts in which they are incorporated in the composition are within the knowledge of those skilled in the art.
  • the present invention also provides an acne treatment package for storing and dispensing the above described aqueous and anhydrous compositions onto the skin.
  • the package comprises a first chamber and a second chamber, each chamber having an outlet thereto, wherein said anhydrous composition is stored in said first chamber and said aqueous composition is stored in said second chamber, said compositions being stored in isolation from each other and being arranged to be combined after passing though said respective outlets onto the skin. On combination of the compositions, heat is generated, effective to raise the temperature of the skin.
  • each composition passes through the outlet of the chamber in which it is stored.
  • the outlets may be adjacent so that on expelling the compositions from the package at the same time, they may be combined after they pass through the outlets onto the skin. It may be desired however to expel the compositions separately, for example to apply one composition and then target the second composition in the area of the first composition. In this case it is not necessary that the outlets of each chamber are near to each other. Although a heating effect is obtained as soon as the water comes into contact with the component that generates heat on contact with water, it is preferred to mix the compositions by rubbing them into the skin.
  • the package further comprises a dispensing nozzle through which the combined compositions are dispensed onto the skin.
  • the aqueous and anhydrous compositions may be combined in the dispensing nozzle or a chamber leading thereto and then targeted onto the affected area of the skin.
  • the package comprises a receptacle partitioned into first and second chambers.
  • the package comprises a dispensing nozzle in which the aqueous and anhydrous compositions may be combined before being expelled onto the skin.
  • the package comprises a tube comprising an anhydrous or aqueous composition and an inner tube comprising the other of said anhydrous or aqueous composition.
  • the inner tube is encompassed within an outer tube which forms the packaging.
  • the package is squeezable to expel said anhydrous or aqueous compositions.
  • a method according to the invention including a method of treating acne comprising the topical administration of an acne active ingredient in the presence of a component that in the presence of water generates heat, may be a therapeutic method, but will often be a primarily cosmetic method, the objective of which is to reduce or eliminate externally visible, and often unsightly, symptoms of acne.
  • FIG. 1 shows a side view of a package comprising an inner tube containing a first composition located within a clear outer tube containing a second composition;
  • FIG. 2 shows a perspective view of one end of a tube comprising a first dispensing nozzle
  • FIG. 3 shows an end view of a second dispensing nozzle
  • FIG. 4 shows a sectional view of a partitioned package comprising first and second chambers
  • FIG. 5 shows an expanded perspective view of the dispensing nozzle from a partitioned package.
  • an acne treatment package ( 2 ) for dispensing first and second compositions onto the skin comprises an outer tube ( 4 ) which provides a first chamber and an inner tube ( 6 ) which provides a second chamber, the contents of the first chamber being isolated from the second chamber.
  • the outer tube has a cap ( 8 ).
  • An aqueous composition which comprises an acne active ingredient is stored in said first (outer) chamber and an anhydrous composition which comprises an acne active ingredient and a component that in the presence of water generates heat on the skin is stored in said second (inner) chamber.
  • the anhydrous composition is present in the outer tube and the aqueous composition is present in the inner tube.
  • the acne active ingredient is present in either one of the anhydrous or aqueous compositions.
  • At least one surfactant is present in either one of or both of the anhydrous and aqueous compositions.
  • the package comprises a neck which forms a dispensing nozzle ( 10 ).
  • the inner tube has an outlet leading into a central channel ( 12 ) of the dispensing nozzle.
  • the outer tube has an outlet leading to a plurality of openings ( 14 ) around the periphery of the dispensing nozzle.
  • the dispensing nozzle ( 10 ) is placed on or near the affected area of the skin and the outer and inner tubes squeezed simultaneously.
  • the anhydrous composition is expelled through the central channel ( 12 ) and the aqueous composition is expelled from the plurality of openings ( 14 ).
  • the compositions are expelled from the package they are combined as they pass onto the skin.
  • the combined compositions are rubbed together into the skin which causes heat to be generated.
  • the combined formulation is then rinsed from the skin.
  • FIG. 3 shows an embodiment where the central passage ( 12 ) is enlarged towards the periphery of the dispensing nozzle and allows a greater amount of the composition in the inner tube to be expelled at a given time in relation to the amount of composition expelled from the openings ( 14 ) in the outer tube.
  • FIG. 4 shows a section view of a partitioned package ( 16 ) providing first ( 18 ) and second ( 20 ) chambers.
  • the anhydrous composition is stored in the first chamber ( 18 ).
  • the aqueous composition is stored in the second chamber ( 20 ).
  • FIG. 5 shows a perspective view of one end of the partitioned package ( 16 ) which is in the form of a tube.
  • the package comprises a neck which forms a dispensing nozzle ( 22 ).
  • the dispensing nozzle is divided down the middle to form two semi-circular channels.
  • a first channel connects the first chamber ( 18 ) with a dispensing aperture ( 24 ).
  • a second channel connects the second chamber ( 20 ) with a dispensing aperture ( 26 ).
  • the dispensing nozzle ( 10 ) When it is desired to apply the combined compositions to the skin, the dispensing nozzle ( 10 ) is placed on or near the affected area of the skin and the tube ( 16 ) squeezed. The anhydrous composition is expelled from the aperture ( 24 ) and the aqueous composition is expelled from the aperture ( 26 ). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
  • the ingredients are available as follows; Carrier 1 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer is available from Penreco under the trade name Versagel M-1600; Carrier 2 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer and is available from Penreco under the trade name Versagel R-500; Thickener 1 is a combination of Glyceryl Dibehenate, Tribehenin and Glyceryl Behenate and is available form Gattefosse under the tradename Compritol ATO 888; Thickener 2 is polyoxyethylene cetyl ether available under the tradename Brij 56; Acrylates/Vinyl Isodecanoate crosspolymer is available from 3V under the tradename Stabylen-30; The polyamide resin is available from Arizona Chemical under the tradename Syl
  • any one of the heating compositions illustrated below may be combined with any of the aqueous compositions illustrated below.
  • the compositions are rubbed together on the skin and after a desired period may be rinsed off.
  • a sheet of vitro-skin was accurately cut using a guillotine into 10 equal pieces. Each of these pieces was then numbered and weighed before the addition of sebum. Sebum was added to the skin as a solid that could be rubbed across the whole of the skin surface (matte side) until the whole surface was covered ( ⁇ 0.2 g). Each piece of skin was then weighed once more before being placed in the hydration chamber.
  • the hydration chamber was prepared by adding a mixture of Glycerine (44 g) and DI water (256 g) to the bottom of it. The skin was then placed on the contained shelves and allowed to stand, with the lid tightly in place for approximately 24 hours at ambient conditions in order to ensure a realistic level of vitro-skin hydration.
  • the lid was removed and cleansing tests were carried out on the skin.
  • the vitro-skin was placed on a foam surface to mimic the non-solidity of skin.
  • the vitro-skin was left to dry on the shelves provided in the hydration chamber.
  • test samples were:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a method of treating acne by the topical administration of an acne active ingredient in the presence of a) an anhydrous composition comprising a component that in the presence of water generates heat, and b) water. The invention also relates to an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat on the skin to which it is applied and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.

Description

  • The present invention relates to a method of treating acne, to an acne treatment kit, to compositions and kits useful in such methods and to processes to prepare said composition and/or kits.
  • Acne vulgaris (acne) is a chronic inflammatory condition of the pilosebaceous units of the skin, which is particularly prevalent in adolescents. The condition generally causes the formation, on the skin, of comedones, red papules, pustules and sometimes cysts. This is unsightly and furthermore, if untreated, acne can lead to scarring of the skin. The major causes of acne are thought to be an increase in sebum production, an increased presence of Propionibacterium acne (P. acne), blockage of the pilosebaceus duct and the production of inflammation.
  • Remedies for the topical treatment of acne generally provide for the application to the affected area of a skincare composition comprising at least one ingredient effective to treat acne. Such actives include the classes of topical retinoids, antibiotics, anti-bacterials and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide and salicylic acid.
  • It has now been found that an improved acne treatment may be achieved by the topical administration of an acne active ingredient in the presence of a component that generates heat on the skin.
  • It has been found that the above treatment provides improved efficacy in the topical treatment of acne. For example, factors including improved sebum removal and improved pore cleansing may lead to a reduction in the number and intensity of acne lesions.
  • Accordingly, the present invention provides a method of treating acne comprising the topical administration of an acne active ingredient in the presence of
      • a) an anhydrous composition comprising a component that in the presence of water generates heat on the skin, and
      • b) water.
  • In another aspect the present invention also provides an acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.
  • In a yet further aspect the present invention provides a skincare formulation obtained by mixing on, or prior to application to, the skin comprising
      • a) a first composition which is anhydrous and comprises a component that in the presence of water generates heat;
      • b) a second composition which comprises an aqueous carrier; and
      • c) at least one acne active ingredient.
  • In still a further aspect the present invention provides an anhydrous composition for the treatment of acne comprising an acne active ingredient, a component that in the presence of water generates heat and a carrier therefor.
  • The invention also provides an acne treatment package for dispensing a first and a second composition onto the skin, said first composition being anhydrous and comprising a component that in the presence of water generates heat and said second composition comprising an aqueous component, at least one of said compositions comprising an acne active ingredient, wherein said package comprises a first chamber and a second chamber, each of said first and second chambers having an outlet, wherein said first composition is stored in said first chamber and said second composition is stored in said second chamber, said compositions being stored in isolation from each other and the package being arranged such that said first and second compositions are combined after passing though each respective outlet.
  • The invention also provides a process of dispensing an acne treatment onto the skin comprising the application to the skin of a first composition which is anhydrous and comprises a component that in the presence of water generates heat, and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, and mixing said compositions to generate heat on the skin.
  • The invention also provides a process to prepare an acne treatment kit, comprising inserting a first composition which is anhydrous and comprises a component that in the presence of water generates heat into a first chamber of a multi-chambered package and inserting a second composition which comprises an aqueous carrier into a second chamber of said package, at least one of said compositions comprising an acne active ingredient, and providing means for combining said compositions on, or prior to application to, the skin.
  • Where reference is made herein to an anhydrous composition, this means a composition which is substantially free of water; for example, it will contain less than 2% by weight water preferably less than 1% by weight water and most preferably less than 0.1% by weight water.
  • In a method according to the invention, an acne active ingredient is applied to the skin in the presence of an anhydrous composition comprising a component that in the presence of water generates heat and water. The heat is generated on the skin and is useful to raise the temperature on the surface of the skin. The amount of heat-generating component present in the anhydrous composition is a level that the heat generated by the combination of the anhydrous composition with the water is acceptable on the skin of a user and does not burn the skin.
  • In accordance with the present invention, the anhydrous composition may be applied to the skin and water applied thereto. The water may be applied before, at the same time as, or after the application of the anhydrous composition. Preferably the anhydrous composition and water are combined by rubbing the ingredients together. In this way the heat generating component is most effectively combined with water to provide a heating effect on the skin.
  • The water may be obtained from any suitable source, for example a water tap. The water may also be provided in an aqueous composition which may include one or more additional ingredients, especially skincare ingredients. There may be sufficient water already present on the skin to produce a suitable heating effect if the anhydrous composition is rubbed into the skin with sufficient vigour.
  • Preferably, the aqueous composition forms part of a package in combination with the anhydrous composition, which allows a measured amount of water to be applied to the skin thus allowing more control of the heating effect.
  • In one embodiment, the administration of the anhydrous composition and the aqueous composition on the skin is substantially simultaneous. The anhydrous composition and aqueous composition may be combined just prior to application to the skin or they may be combined on the skin. For example, the anhydrous composition and aqueous composition may be dispensed from separate chambers within a package. The outlet of each chamber may allow the compositions to be applied directly onto the skin and then combined by the user rubbing the compositions on the surface of the skin or the compositions may be combined as they pass through a dispensing nozzle before application to the skin.
  • A skincare formulation is provided when said anhydrous composition is combined with water. Heat is generated on the skin which enhances the effect of the acne active ingredient. The skincare formulation may be left on the skin in which case the heat generated will gradually subside. Preferably the composition is rinsed off the skin, leaving a therapeutically effective amount of the acne active ingredient on the skin.
  • The acne active ingredient may be present separate from the anhydrous composition or the aqueous composition, it may be present in either the anhydrous and aqueous compositions or it may be present in both the anhydrous and aqueous compositions.
  • The acne active ingredient may be selected from any class of materials that are effective to treat acne, including topical retinoids, antibiotics, anti-microbials, anti-bacterials, anti-inflammatory agents and keratolytic agents, for example tretinoin, adapalene, tazarotene, clindamycin, erythromycin, azelaic acid, benzoyl peroxide, hydrogen peroxide and salicylic acid. If desired two or more acne active ingredients may be employed. The active ingredients may be present in the same or in different compositions.
  • The active ingredient is present in the formulation in a therapeutically effective amount, as generally known in the art. For most active ingredients, a range from 0.001% to 10% by weight, especially from 0.1% to 10% by weight, could be expected. Thus, generally each composition may comprise the above recited amount of acne active ingredient. Preferably, an acne active ingredient is present in an amount of 0.1% to 5% by weight of the anhydrous composition. Further preferably, an acne active ingredient is present in an amount of 0.1% to 5% by weight of the aqueous composition. However, it may be a benefit to reduce the total amount of any one active in the anhydrous or aqueous compositions, or to separate a plurality of actives, by including at least one acne active ingredient in both compositions. Thus, in a preferred embodiment, an acne active ingredient is present in an amount from 0.1% to 5% by weight of both aqueous and anhydrous compositions.
  • In one embodiment, said acne active ingredient is a keratolytic agent such as salicylic acid. Salicylic acid is preferably incorporated into the composition according to the invention as the free acid. However, the pH of the composition may, and generally will, be such that the salicylic acid exists in the composition in dissociated form. As the composition may well contain cationic counterions, the salicylic acid may then be thought of as being present in salt form. Alternatively, the salicylic acid may be incorporated into the composition in salt form, eg as a salt with a Group I metal, such as sodium salicylate. As used herein, unless the context requires otherwise, any and all references to salicylic acid should be taken to encompass references to the acid and to dissociated forms and salts thereof.
  • The total concentration of salicylic acid in the formulation according to the invention, ie the combined anhydrous and aqueous compositions, is preferably at least 0.1% by weight, more preferably at least 0.5% by weight, most preferably at least 1.0% and especially at least 1.5% by weight. The concentration of salicylic acid is preferably less than 10% by weight, more preferably less than 6% by weight, and most preferably less than 4% by weight. Conveniently, the total concentration of salicylic acid may fall in the range 0.1% to 10% by weight, preferably 0.5% to 10% by weight, more preferably 1.0% to 6%, and most preferably 1.5% to 4.0% by weight. A particularly preferred total concentrations of salicylic acid is approximately 1.5-2% by weight of the composition.
  • In one embodiment, said acne active ingredient, preferably salicylic acid, is present in the anhydrous and aqueous compositions. The amount of acne active ingredient may be different in each composition. However, preferably, the aqueous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient. Further preferably, the anhydrous composition comprises from 0.5% to 4% by weight, more preferably 1% to 3% by weight, acne active ingredient.
  • In accordance with the invention, any pharmaceutically acceptable component that generates heat in the presence of water may be used. Preferred examples are selected from the group of materials that generate heat within the classes of zeolites (aluminosilicates); metal halides, sulphates, carbonates and oxides; and polyhydric alcohols. Preferred classes of materials include zeolites and bivalent metal halides. These materials are well known to those skilled in the art. Examples of bivalent metal halides and oxides may include magnesium chloride, iron chloride, zinc chloride, magnesium oxide, calcium oxide, magnesium sulphate and calcium chloride.
  • Such heat generating materials will suitably be present in the anhydrous composition in an amount to heat the skin to facilitate opening and cleansing of the pores. For example, such materials my be used in an amount of up to 70% by weight of the anhydrous composition, for example, from 1% to 70% by weight, preferably from 1% to 40% by weight, more preferably from 1% to 25% by weight and most preferably from 1% to 15% by weight.
  • The person skilled in the art will appreciate that the heat generated must be less than that which will cause heat damage to the skin. Preferably the temperature of the skin is raised by no more than 50° C. In order to be effective, preferably, the temperature of the skin is raised by at least 2° C., more preferably at least 10° C. Conveniently, the temperature of the skin may be raised to a temperature in the range 4° C. to 70° C., preferably 4° C. to 15° C.
  • Preferably, the component that in the presence of water generates heat comprises a bivalent metal halide, further preferably a metal halide selected from magnesium chloride, iron chloride, zinc chloride and calcium chloride, most preferably magnesium chloride.
  • In one embodiment of the invention, the anhydrous composition comprises from 5% to 60% by weight, preferably from 10% to 50% by weight, more preferably from 12% to 40% by weight and most preferably from 15% to 35% by weight of said water-activatable, heat-generating component.
  • In accordance with the invention, the anhydrous composition comprises an anhydrous carrier. Conveniently, this may be an oily material. A physiologically effective oil useful in accordance with the present invention may be any cosmetically and/or dermatologically acceptable synthetic or natural oil known to the person skilled in the art. Such oils may also provide emollient properties on the skin, for example to maintain the soft, smooth and pliable appearance of the skin. Suitable ingredients include hydrocarbons, silicone oils, triglycerides, waxes, fatty acids, fatty acid alcohols and esters thereof, mineral oils, vegetable oils and hydrogenated vegetable oils, lanolin or mixtures thereof. Examples of hydrocarbons include paraffins (for example paraffinum liquidum and white soft paraffin), petrolatum, hydrogenated polyisobutene, alkyl benzoates, isohexadecane, isododecane, isononyl isonanoate, diisopropylcyclohexane; examples of silicone oils include dimethicone, cyclomethicone or cetyldimethicone; examples of triglycerides include natural triglycerides and synthetic or semi-synthetic triglycerides; examples of waxes include vegetable waxes such as carnauba wax, animal waxes such as beeswax, and mineral waxes such as paraffin wax, ozokerite; examples of esters of fatty acids or alcohols include isopropyl palmitate, isopropyl myristate, dioctylmaleate, glyceryl oleate and cetostearyl isononanoate, octyl palmitate; examples of mineral oils include Vaseline oil; examples of vegetable oils include jojoba oil, soy bean oil, coconut oil, sunflower seed oil, apricot kernel oil, shea butter, avocado oil and examples of hydrogenated vegetable oils include hydrogenated palm oil.
  • Such materials may be used in an amount greater than 30% by weight, more preferably greater than 35% by weight, advantageously greater than 40% by weight and most preferably greater than 45% by weight of the composition. The carrier generally provides the largest component by weight of the anhydrous composition. Preferably, the anhydrous composition comprises from 30% to 99% by weight, preferably from 35% to 95% by weight, more preferably from 40% to 90% by weight and most preferably from 50% to 85% by weight of said carrier.
  • In one embodiment, the anhydrous carrier comprises a mineral oil. Preferably, the mineral oil is blended with a styrene copolymer, for example a hydrogenated alkylene-styrene copolymer, more preferably a hydrogenated butylene/ethylene/styrene copolymer or a hydrogenated ethylene/propylene/styrene copolymer or a mixture thereof. A particularly preferred source of a mineral oil/styrene copolymer blend is available under the tradename Versagel from Penreco, 138 Petrolia Karns City USA.
  • Preferably, mineral oil is combined with a hydrogenated alkylene-styrene copolymer/mineral oil blend.
  • In preferred compositions which comprise mineral oil, the total mineral oil is preferably present in an amount from 50% to 85% by weight, more preferably from 60% to 80% by weight, of the anhydrous composition; conveniently this may be a blend comprising mineral oil in an amount from 25% to 60% by weight (more preferably from 35% to 50% by weight) and a mineral oil/styrene copolymer blend in an amount from 20% to 40% by weight (more preferably from 24% to 32% by weight).
  • In another embodiment, the anhydrous composition comprises a surfactant. This forms a particularly preferred aspect of the present invention as it provides a composition with advantageous viscosity and skin-feel properties. For example, it may provide a less oily feel to the composition so that it is more pleasant to apply and retain on the skin. For example, a greasy and/or oily and/or sticky feel on the skin may be reduced. In particular, the inclusion of a surfactant in a composition where the carrier is a hydrocarbon (such as mineral oil) improves the aesthetic feel of the composition on the skin. In this way, it has been found that less expensive carriers may be employed in the anhydrous composition. Furthermore, the anhydrous composition has good viscosity properties as it is not too viscous to apply and does not run off the skin when applied thereto. A suitable viscosity is that of a thickened liquid such that it is thicker than water and preferably remains in the area to which it is applied, even when the user moves or applies it to a non-horizontal skin surface. It is a preferred feature of the invention that the compositions have a viscosity which allow them to be dispensed conveniently from a package, especially through a dispensing nozzle. The viscosity range values of such compositions will be known to those skilled in the art. The inclusion of at least one surfactant may provide that it may not be necessary to include a thickening component in the composition. In one embodiment, the anhydrous composition comprises a surfactant and does not include a thickening component.
  • The surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Examples of non-ionic surfactants include the class of ethoxylated fatty alcohols and other surfactants such as oleth-5, PEG-5 cocamide, polysorbate 20, PEG-40 hydrogenated castor oil, alkyl poly(ethylene oxide), copolymers of poly(ethylene oxide) and poly(propylene oxide) (commercially called Poloxamers or Poloxamines), alkyl polyglucosides, including: octyl glucoside, decyl maltoside, fatty alcohols, cetyl alcohol, oleyl alcohol; examples of anionic surfactants includes the class of alkyl ether sulphates, such as sodium lauryl sulphate, sodium laureth sulphate, sodium dodecyl sulfate, ammonium lauryl sulfate, ammonium laureth sulphate, sodium C12-15 pareth sulphate and disodium laureth sulfosuccinate, soaps or fatty acid salts; examples of cationic surfactants include cationic modified guar, alkyltrimethylammonium salts, for example cetrimonium chloride, cetyl trimethylammonium bromide, cetylpyridinium chloride, polyethoxylated tallow amine, benzalkonium chloride, benzethonium chloride and behentrimonium chloride; examples of amphoteric surfactants include the class of alkylamido alkyl amines and dodecyl betaine, dodecyl dimethylamine oxide, cocamidopropyl betaine, cocamidopropyl hydroxysultaine, sodium lauroamphoacetate, cocoamphoglycinate or sodium cocoamphoacetate. A further preferred group of classes of surfactants are alkyl sulphates, alkyl ether sulphates, alpha-olefin sulphates, alkylsarcosinates and aryl-sulphonated derivatives thereof.
  • Preferably, the surfactant comprises an anionic surfactant, optionally in combination with other surfactants. Most preferably, the surfactant comprises an alkali metal sulphate, such as sodium lauryl sulphate and/or sodium dodecyl sulphate.
  • Preferably, when present, the anhydrous composition comprises from 1-20% by weight surfactant, further preferably from 1% to 10% by weight, more preferably from 3% to 15% by weight and most preferably from 4% to 10% by weight surfactant.
  • In one embodiment, the present invention provides an anhydrous composition comprising
      • (a) 1% to 5% by weight salicylic acid;
      • (b) 10% to 35% by weight magnesium chloride;
      • (c) 4% to 10% by weight surfactant; and
      • (d) 50% to 85% by weight carrier.
  • Further preferably, the anhydrous composition consists essentially of the above ingredients.
  • In one embodiment of the present invention, the aqueous composition is a cleansing composition comprising a surfactant. The surfactant may be an anionic, non-ionic, cationic and zwitterionic/amphoteric surfactant. Any conventionally used pharmaceutically and cosmetically acceptable surfactant may be used and these will be known to the person skilled in the art. Particular surfactants may be as described above with respect to the anhydrous composition. Preferably, the surfactant comprises an anionic surfactant and/or a non-ionic surfactant. Preferred materials include lauryl or laureth sulphates (such as sodium or triethanolamine lauryl/laureth sulphates) and polypropyleneglycols, polyethylene glycols and derivatives thereof.
  • In preferred compositions, it is desired that the total surfactant concentration in the aqueous and anhydrous compositions when combined to provide the formulation, is sufficient such that when rubbed into the skin, a foam is produced which can be rinsed off the skin.
  • The aqueous and anhydrous compositions may also include other skincare ingredients as desired, for example emollients, humectants, film formers, cooling agents, soothing agents, anti-inflammatories.
  • In particular, the anhydrous and aqueous compositions may also comprise thickening agents which increase the viscosity of the composition. Examples include polyethylene glycols; polyoxyethylene cetyl ethers; Acrylates/Vinyl Isodecanoate crosspolymer, polyamide resins such as Sylvaclear (tradename), lanolin, stearyl alcohol and salt.
  • In one embodiment, the present invention provides an aqueous composition comprising
      • (a) 1% to 5% by weight salicylic acid;
      • (b) 5% to 85% by weight surfactant; and
      • (c) 10% to 94% by weight water.
  • Further preferably, the aqueous composition consists essentially of the above ingredients.
  • Preferably, when present, the anhydrous and/or aqueous compositions comprise from 1-20% by weight thickener, more preferably from 2% to 15% by weight and most preferably from 3% to 10% by weight thickener.
  • The aqueous and anhydrous compositions provided in accordance with the present invention are suitably in the form of a liquid or a gel, preferably as a viscous liquid.
  • In accordance with the present invention, the anhydrous and aqueous compositions may comprise other conventional ingredients, such as anti-microbial agents, sequestering agents, colouring agents and perfumes. Such ingredients and the amounts in which they are incorporated in the composition are within the knowledge of those skilled in the art.
  • The present invention also provides an acne treatment package for storing and dispensing the above described aqueous and anhydrous compositions onto the skin. The package comprises a first chamber and a second chamber, each chamber having an outlet thereto, wherein said anhydrous composition is stored in said first chamber and said aqueous composition is stored in said second chamber, said compositions being stored in isolation from each other and being arranged to be combined after passing though said respective outlets onto the skin. On combination of the compositions, heat is generated, effective to raise the temperature of the skin.
  • In expelling a portion of the contents of the package, each composition passes through the outlet of the chamber in which it is stored. The outlets may be adjacent so that on expelling the compositions from the package at the same time, they may be combined after they pass through the outlets onto the skin. It may be desired however to expel the compositions separately, for example to apply one composition and then target the second composition in the area of the first composition. In this case it is not necessary that the outlets of each chamber are near to each other. Although a heating effect is obtained as soon as the water comes into contact with the component that generates heat on contact with water, it is preferred to mix the compositions by rubbing them into the skin.
  • In one embodiment, the package further comprises a dispensing nozzle through which the combined compositions are dispensed onto the skin. The aqueous and anhydrous compositions may be combined in the dispensing nozzle or a chamber leading thereto and then targeted onto the affected area of the skin.
  • In one embodiment the package comprises a receptacle partitioned into first and second chambers. Preferably, the package comprises a dispensing nozzle in which the aqueous and anhydrous compositions may be combined before being expelled onto the skin.
  • In another embodiment the package comprises a tube comprising an anhydrous or aqueous composition and an inner tube comprising the other of said anhydrous or aqueous composition. Suitably, the inner tube is encompassed within an outer tube which forms the packaging.
  • Preferably, the package is squeezable to expel said anhydrous or aqueous compositions.
  • It will be appreciated that a method according to the invention, including a method of treating acne comprising the topical administration of an acne active ingredient in the presence of a component that in the presence of water generates heat, may be a therapeutic method, but will often be a primarily cosmetic method, the objective of which is to reduce or eliminate externally visible, and often unsightly, symptoms of acne.
  • The invention will now be described in more detail, by way of illustration only, with reference to the accompanying drawings.
  • In the drawings:
  • FIG. 1 shows a side view of a package comprising an inner tube containing a first composition located within a clear outer tube containing a second composition;
  • FIG. 2 shows a perspective view of one end of a tube comprising a first dispensing nozzle;
  • FIG. 3 shows an end view of a second dispensing nozzle;
  • FIG. 4 shows a sectional view of a partitioned package comprising first and second chambers;
  • FIG. 5 shows an expanded perspective view of the dispensing nozzle from a partitioned package.
  • Referring firstly to FIG. 1, an acne treatment package (2) for dispensing first and second compositions onto the skin comprises an outer tube (4) which provides a first chamber and an inner tube (6) which provides a second chamber, the contents of the first chamber being isolated from the second chamber. The outer tube has a cap (8).
  • An aqueous composition which comprises an acne active ingredient is stored in said first (outer) chamber and an anhydrous composition which comprises an acne active ingredient and a component that in the presence of water generates heat on the skin is stored in said second (inner) chamber.
  • In another embodiment, the anhydrous composition is present in the outer tube and the aqueous composition is present in the inner tube.
  • In a further embodiment, the acne active ingredient is present in either one of the anhydrous or aqueous compositions.
  • In a further embodiment, at least one surfactant is present in either one of or both of the anhydrous and aqueous compositions.
  • Referring to FIG. 2, the package comprises a neck which forms a dispensing nozzle (10). The inner tube has an outlet leading into a central channel (12) of the dispensing nozzle. The outer tube has an outlet leading to a plurality of openings (14) around the periphery of the dispensing nozzle.
  • In use, the dispensing nozzle (10) is placed on or near the affected area of the skin and the outer and inner tubes squeezed simultaneously. The anhydrous composition is expelled through the central channel (12) and the aqueous composition is expelled from the plurality of openings (14). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
  • FIG. 3 shows an embodiment where the central passage (12) is enlarged towards the periphery of the dispensing nozzle and allows a greater amount of the composition in the inner tube to be expelled at a given time in relation to the amount of composition expelled from the openings (14) in the outer tube.
  • FIG. 4 shows a section view of a partitioned package (16) providing first (18) and second (20) chambers. The anhydrous composition is stored in the first chamber (18). The aqueous composition is stored in the second chamber (20).
  • FIG. 5 shows a perspective view of one end of the partitioned package (16) which is in the form of a tube. The package comprises a neck which forms a dispensing nozzle (22). The dispensing nozzle is divided down the middle to form two semi-circular channels. A first channel connects the first chamber (18) with a dispensing aperture (24). A second channel connects the second chamber (20) with a dispensing aperture (26).
  • When it is desired to apply the combined compositions to the skin, the dispensing nozzle (10) is placed on or near the affected area of the skin and the tube (16) squeezed. The anhydrous composition is expelled from the aperture (24) and the aqueous composition is expelled from the aperture (26). As the compositions are expelled from the package they are combined as they pass onto the skin. The combined compositions are rubbed together into the skin which causes heat to be generated. The combined formulation is then rinsed from the skin.
  • In the following examples, there are described several preferred embodiments to illustrate the invention. However, it is to be understood that the invention is not to be limited to the specific embodiments.
  • In the examples, the ingredients are available as follows; Carrier1 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer is available from Penreco under the trade name Versagel M-1600; Carrier2 is a blend of mineral oil and ethylene/propylene/styrene copolymer and butylene/ethylene/styrene copolymer and is available from Penreco under the trade name Versagel R-500; Thickener1 is a combination of Glyceryl Dibehenate, Tribehenin and Glyceryl Behenate and is available form Gattefosse under the tradename Compritol ATO 888; Thickener2 is polyoxyethylene cetyl ether available under the tradename Brij 56; Acrylates/Vinyl Isodecanoate crosspolymer is available from 3V under the tradename Stabylen-30; The polyamide resin is available from Arizona Chemical under the tradename Sylvaclear AF1900V; Triethanolamine laureth sulphate (TEA-LS) is available under the tradename Sunform-T7; cocamidopropyl betaine is available under the trade name Incronam 30; PEG-150 is available under the tradename Crothix liquid; PEG-150 Pentaerythrityl Tetrastearate is available from Crothix;
  • Any one of the heating compositions illustrated below may be combined with any of the aqueous compositions illustrated below. The compositions are rubbed together on the skin and after a desired period may be rinsed off.
  • Heating Compositions
  • The ingredients listed in each example below were combined by mixing according to conventional methods.
  • EXAMPLES 1-4
  • Examples
    Materials 1 2 3 4
    Carrier1 38.5% 38.5%
    Carrier2 38.5% 38.5%
    Light 45% 45% 45% 45%
    Mineral oil
    Salicylic 1.5%  1.5%  1.5%  1.5% 
    acid
    MgCl2 15% 15%
    Zeolite 15% 15%
  • EXAMPLES 5-10
  • Examples
    Materials 5 6 7 8 9 10
    Carrier2 38.5% 25% 15.5% 15.5% 13%
    Light 25% 31.8% 60% 60% 33.5% 35%
    Mineral oil
    Salicylic 1.5%   1.5% 1.5%  1.5%  1.5%  1.5% 
    acid
    Butylene
    20% 26.7% 30% 15.5%
    glycol
    Thickener1  8%  8%
    MgCl2 15% 15% 15%
    Zeolite 15% 15% 15%
    PEG-8 10% 10%
    Thickener2 10% 10%
  • EXAMPLES 11-14
  • Examples
    Materials 11 12 13 14
    Carrier2 13.5% 13.5% 7%
    Light 68.5%   60.5%
    Mineral oil
    Salicylic 1.5%  1.5%  1.5%  1.5%
    acid
    Butylene 50% 45%
    glycol
    Thickener1 8%   8%
    Zeolite 15% 30% 15%  30%
    PEG-8 10%  5%
    Brij 56 10%  5%
  • EXAMPLES 15-17
  • Examples
    Materials 15 16 17
    Salicylic acid 1.5%  1.5%  1.5% 
    Butylene glycol 40% 26% 25%
    Glycerine
    26% 40% 40%
    Acrylates/Vinyl  1%
    Isodecanoate
    crosspolymer
    Zeolite 25% 25% 25%
    PEG-8 7.5%  7.5%  7.5% 
  • EXAMPLES 18-20
  • Examples
    Materials
    18 19 20
    Salicylic acid 1.5%   1.5% 1.5% 
    Butylene glycol 38.5%
    Light mineral oil 59.5% 45.5%
    Carrier1 15%
    MgCl2 35% 35% 35%
    PEG-8  5%
    polyamide resin  5%
    Polypropylene glycol (PPG)-14 15%
    Thickener1   4%  3%
  • EXAMPLES 21-25
  • Examples
    Materials 21 22 23 24 25
    Salicylic acid 1.5%  1.5% 1.5% 1.5%  1.5% 
    Carrier1 27.5%  15%  15% 15% 15%
    Thickener
    1  6% 2.7% 8.2%  3%  6%
    Mineral oil 40%  45%  40% 45% 42.5%
    MgCl2 25%  35%  35% 35% 35%
    Fragrance 0.3% 0.3%
  • EXAMPLES 26-28
  • Materials 26 27 28
    Salicylic acid 1.5%  1.5% 1.5% 
    Carrier1 15%  10% 10%
    Thickener1 2.5%
    Mineral oil 43.5% 48.5%  43.5%
    Sodium Dodecyl Sulfate  5% 2.5% 10%
    MgCl2 35%  35% 35%
  • EXAMPLES 29-30
  • Materials 29 30
    Salicylic acid  2%  2%
    Carrier1 15% 30%
    Mineral oil 48% 43%
    Sodium Dodecyl Sulfate  5%  5%
    MgCl2 30% 20%
  • Aqueous Cleansing Compositions
  • The ingredients listed in each example below were combined by mixing according to conventional methods.
  • EXAMPLES 31-34
  • Examples
    Materials 31 32 33 34
    Water 27% 20% 25% 25%
    Salicylic acid 1.5%  1.5%  1.5%  1.5% 
    Butylene glycol 15%
    Polyamide resin  3%
    Glycerol 25% 15% 15%
    Ethanol 45% 45% 45% 45%
    Menthol (L) 3.5%  3.5% 
    Menthol (D/L) 3.5%  3.5% 
    TEA - Laureth Sulphate  5%  5%
    PEG - 8  5%  5%  5%  5%
  • EXAMPLES 35-40
  • Examples
    Materials 35 36 37 38 39 40
    Salicylic acid  2%  2%  2% 2%  2%  2%
    Butylene glycol 35% 30% 20% 22%  35%
    Glycerol 25% 20% 30% 30%  40% 25%
    PEG-7 glyceryl cocoate 2.5%  2.5%   4% 3%  2%  2%
    PEG-150 Pentaerythrityl  5%  5%  4% 4% 10%  3%
    Tetrastearate
    PEG-8 2.5%  2.5%   4% 3%  2%  3%
    polyamide resin  5% 15%  3%
    PPG -14 butyl ether 10% 13%  13%
    Water 13% 13% 13% 3% 21% 20%
    Sodium Lauryl Sulphate 10% 10% 10% 20%  10%
    (30% in water)
    Cocamidopropyl Betaine 10%
  • EXAMPLES 41-44
  • Examples
    Materials 41 42 43 44
    Salicylic acid 2% 2% 2% 2%
    Butylene glycol 35%  35%  30%  30% 
    Glycerol
    20%  20%  20%  20% 
    PEG-7 glyceryl cocoate 2% 2% 2% 2%
    PEG-8 2% 2% 2% 2%
    Hydrolysed milk protein 0.2% 0.2% 0.2% 0.2%
    PPG -14 butyl ether 10%  10%  5% 6%
    cocamidopropyl betaine 2.3% 2.9% 2.8%
    Sodium Lauryl Sulphate 7.5% 5.3% 6.7% 6.7%
    (30% in water)
    Lanolin 1% 0.5%
    Stearyl alcohol 2% 1.5%
    Sodium Chloride 1% 1% 1% 1%
    PEG - 150 3% 3%
    Water to 100%   to 100%   to 100%   to 100%  
  • EXAMPLES 45-49
  • Examples
    Materials 45 46 47 48 49
    Butylene Glycol  30%  30%  30%  30% 30% 
    Glycerine
     20%  20%  20%  20% 20% 
    PEG-7 1.5% 2% 2% 2.5% 2.5%
    PEG-8 1.5% 2% 2% 2.5% 2.5%
    PPG-14 6.5% 6.5% 6.5% 5% 5%
    Lanolin
    2% 2% 2% 2% 2%
    Stearyl Alcohol 0.5% 1%
    PEG-150 3.5% 2.5% 2.5% 3% 3%
    Sodium lauryl 6.7% 6.7% 6.7% 6.1% 6.1%
    sulphate
    cocamidopropyl 2.8% 2.8% 2.8% 2.8% 2.8%
    betaine
    NaCl 1% 1% 1% 1% 1%
    Salicylic Acid 2% 2% 2% 2% 2%
    Hydrolysed Milk 0.2% 0.2% 0.2% 0.2% 0.2%
    Protein
    Water to 100%   to 100%   to 100%   to 100%   to 100%  
  • EXAMPLES 50-54
  • Examples
    Materials 50 51 52 53 54
    Butylene Glycol 22.5 22.5 22.5 12.5 12.5
    Glycerine 15 15 15 5 5
    PEG-7 2.3 2.3 2.3 2.5 2.5
    PEG-8 2.3 2.3 2.3 1.5 1.5
    PPG-14 3.8 3.8 3.8 3.8 3.8
    Lanolin 0.4 0.4 0.4
    Protanal LF 10/60 0.4
    Carrageenan 0.4 1.5
    Carbopol polymer 1 3.8
    Crothix Solid 1.5
    Sodium lauryl 6.5 6.5 6.5 5 2
    sulphate
    Incronam 2.1 2.1 2.1 2.1 2.1
    NaCl 0.4 0.4 0.4 0.8 0.8
    Salicylic Acid 1.5 1.5 1.5 1.5 1.5
    Hydrolysed Milk 0.2 0.2 0.2 0.2 0.2
    Protein
    Colour qs qs qs qs qs
    Fragrance qs qs qs qs qs
    water to 100% to 100% to 100% to 100% to 100%
  • Amounts are shown in g
  • EXAMPLES 55-56
  • Examples
    Materials 55 56
    Butylene Glycol: 6.0000 6.0000
    Glycerine: 3.0000 3.0000
    PEG-7 1.5000 1.5000
    PEG-8 1.5000 1.5000
    PPG-14 3.0000 3.0000
    S.L.S 7.5000 6.3750
    Arrowroot 3.0000 4.5000
    Incronam 1.0500 1.0500
    Water: 44.6250 44.2500
    Sodium chloride 0.7500 0.7500
    Salicylic Acid 1.5000 1.5000
    Hydrolysed Milk Protein 1.5000 1.5000
    Colour qs qs
    Fragrance qs qs
  • EXAMPLES 57-60
  • Examples
    Materials 57 58 59 60
    Sodium hydroxide (25%) 0.86 0.86 0.34 0.8625
    Carbopol CC polymer 3.75 3.75 11.2500
    Glycerine 4.36 11.25 4.5 8.4375
    PEG-7 1.125 1.125 13.5 0.8438
    PEG-8 1.125 1.125 0.15 0.8438
    S.L.S (27%) 7.5 1.13 22.5000
    S.D.S solid 15 1.13
    Cocamidopropyl 7.5 11.25
    betaine (30%)
    Water added 47.2 40.31 11.25 28.6875
    Salicylic Acid 1.5 1.5 29.25 1.5000
    Colour 0.0002 0.0002 1.5 0.0002
    Fragrance 0.075 0.075 0.0002 0.0750
  • EXAMPLES 61-62
  • Examples
    Materials 61 62
    Glycerine: 2.25 2.25
    Water: 43.67 43.67
    NaCl 0.94 0.94
    Salicylic Acid 1.5 1.5
    Hydrolysed Milk Protein 0.15 0.15
    Colour 0.0003 0.0003
    Fragrance 0.15 0.15
    Sodium hydroxide @ 25% 0.14 0.14
    Plantacare 818 UP 6 6
    Texapon NSO 20.25
    Plantapon 611C 20.25
  • EXAMPLES 63-64
  • Materials 63 64
    Salicylic Acid 2 2
    Colour qs qs
    Fragrance qs qs
    Cocoglucoside (50%) 8 8
    Glycerin 2.7 2.7
    Salt (NaCl) 1.2
    Sodium Laureth-2 Sulphate 52 67.7
    (27%)
    Levomenthol 0.1
    Hydrolysed milk protein 0.2
    Sodium chloride 1.1
    Water to 100% to 100%
  • Test Method Skin Preparation:
  • A sheet of vitro-skin was accurately cut using a guillotine into 10 equal pieces. Each of these pieces was then numbered and weighed before the addition of sebum. Sebum was added to the skin as a solid that could be rubbed across the whole of the skin surface (matte side) until the whole surface was covered (˜0.2 g). Each piece of skin was then weighed once more before being placed in the hydration chamber.
  • The hydration chamber was prepared by adding a mixture of Glycerine (44 g) and DI water (256 g) to the bottom of it. The skin was then placed on the contained shelves and allowed to stand, with the lid tightly in place for approximately 24 hours at ambient conditions in order to ensure a realistic level of vitro-skin hydration.
  • Cleansing Method
  • After 24 hours the lid was removed and cleansing tests were carried out on the skin. For all tests, the vitro-skin was placed on a foam surface to mimic the non-solidity of skin.
  • For all samples, 5 ml of DI water at room temperature was accurately syringed onto the surface of the vitro-skin. This was then massaged into the skin using a gloved finger with small circular movements for ten seconds. Once this was done the test sample was applied and massaged into the skin.
  • After cleansing all skin samples were thoroughly rinsed until for a minimum of 30 seconds, or until all visible products had been removed (as would be the case in a realistic situation).
  • After cleansing, the vitro-skin was left to dry on the shelves provided in the hydration chamber.
  • After 24 hours the skin was then re-weighed providing the information that was required to then calculate the percentage of sebum removed from each piece of vitro-skin.
  • All testing carried out on vitro-skin was repeated 5 times for each variable.
  • The test samples were:
    • A: Water
    • B: Part 1—Anhydrous composition comprising mineral oil, surfactant, magnesium chloride and salicylic acid (2% w/w) as illustrated herein.
    • Part 2—Aqueous cleansing composition comprising surfactant and salicylic acid (2% w/w) as illustrated herein
    • C: Aqueous cleansing composition comprising surfactant and salicylic acid (2% w/w) as illustrated herein
  • The test results were as follows:
  • Mass of
    Mass of Skin + Mass of %
    Mass of Skin + Sebum After Sebum Sebum Standard
    Skin. Sebum Cleansing Removed Removed Average Deviation Confidence
    A 0.601 0.798 0.705 0.093 47.2081 32.7214 12.5944 11.039280
    0.599 0.808 0.779 0.029 13.8756
    0.590 0.794 0.735 0.059 28.9216
    0.568 0.762 0.697 0.065 33.5052
    0.561 0.768 0.685 0.083 40.0966
    B 0.581 0.782 0.668 0.114 56.7164 78.6322 5.29019 3.4561965
    0.563 0.771 0.619 0.152 73.0769
    0.565 0.754 0.608 0.146 77.2487
    0.604 0.800 0.629 0.171 87.2449
    0.598 0.783 0.630 0.153 82.7027
    0.463 0.661 0.515 0.146 73.7374
    0.457 0.637 0.503 0.134 74.4444
    0.444 0.626 0.479 0.147 80.7692
    0.467 0.679 0.522 0.157 74.0566
    0.455 0.641 0.484 0.157 84.4086
    C 0.617 0.830 0.704 0.126 59.1549 44.9166 13.0069 11.400818
    0.580 0.790 0.670 0.120 57.1429
    0.560 0.751 0.669 0.082 42.9319
    0.577 0.758 0.693 0.065 35.9116
    0.552 0.749 0.691 0.058 29.4416

Claims (37)

1. A method of treating acne by the topical administration of an acne active ingredient in the presence of
an anhydrous composition comprising a component that in the presence of water generates heat, and
water.
2. A method according to claim 1, wherein the administration of the anhydrous composition and the aqueous composition is substantially simultaneous.
3. A method according to claim 1, wherein said acne active ingredient is present in said anhydrous composition.
4. A method according to claim 1, wherein said acne active ingredient is present in said aqueous composition.
5. A method according to claim 1, wherein the acne active ingredient is a keratolytic agent.
6. A method according to claim 1, wherein the acne active ingredient is present in an amount of from 0.1% to 10% by weight of the combined anhydrous and aqueous compositions.
7. A method according to claim 1, wherein the acne active ingredient is present in an amount of 0.1% to 5% by weight of the anhydrous composition.
8. A method according to claim 1, wherein the acne active ingredient is present in an amount of 0.1% to 5% by weight of the aqueous composition.
9. A method according to claim 1, wherein the component activatable by water to generate heat on the skin is selected from the group consisting of zeolites and bivalent metal halides.
10. A method according to claim 9, wherein the component activatable by water to generate heat on the skin is magnesium chloride.
11. A method according to claim 9, wherein said anhydrous composition comprises from 5% to 60% by weight of said component that generates heat in the presence of water.
12. A method according to claim 1, wherein the anhydrous composition comprises an anhydrous carrier.
13. A method according to claim 12, wherein the anhydrous carrier comprises a hydrocarbon material.
14. A method according to claim 13, wherein the anhydrous carrier comprises mineral oil.
15. A method according to claim 1, wherein the anhydrous composition comprises a surfactant.
16. A method according to claim 15, wherein the surfactant is selected from the group consisting of alkyl sulphates, alkyl ether sulphates, alpha-olefin sulphates, alkylsarcosinates and aryl-sulphonated derivatives thereof.
17. A method according to claim 16, wherein the surfactant is selected from the group consisting of sodium lauryl sulphate and sodium dodecyl sulphate.
18. A method according to claim 15, wherein the anhydrous composition comprises from 1% to 10% by weight surfactant.
19. A method according to claim 1, wherein the aqueous composition is a cleansing composition comprising a surfactant.
20. An acne treatment kit comprising a first composition which is anhydrous and comprises a component that in the presence of water generates heat on the skin to which it is applied and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient, said compositions being stored in isolation from each other and being capable of generating heat when they are combined.
21. A skincare formulation obtained by mixing on, or prior to application to, the skin comprising:
a first composition which is anhydrous and comprises a component that in the presence of water generates heat;
a second composition which comprises an aqueous carrier; and
at least one acne active ingredient.
22. An anhydrous composition for the treatment of acne comprising an acne active ingredient, a component that in the presence of water generates heat and a carrier therefor.
23. A composition according to claim 22, wherein the carrier comprises a hydrocarbon.
24. A composition according to claim 23, wherein said composition comprises a surfactant.
25. A composition according to claim 24, wherein said surfactant is selected from the group consisting of alkyl sulphates and alkyl ether sulphates.
26. A composition according to claim 22 comprising:
1-5% by weight acne active ingredient;
20-40% by weight component that in the presence of water generates heat;
50-85% by weight carrier; and
1-10% surfactant.
27. A composition according to claim 22 in the form of a thickened liquid which does not flow off the skin.
28. An acne treatment package for dispensing a first and a second composition onto the skin, said first composition being anhydrous and comprising a component that in the presence of water generates heat and said second composition comprising an aqueous component, at least one of said compositions comprising an acne active ingredient, wherein said package comprises a first chamber and a second chamber, each of said first and second chambers having an outlet, wherein said first composition is stored in said first chamber and said second composition is stored in said second chamber, said compositions being stored in isolation from each other and the package being arranged such that said compositions are combined after passing though said respective outlet.
29. A package according to claim 28 further comprising a dispensing nozzle through which the combined compositions are dispensed onto the skin.
30. A package according to claim 28 further comprising a receptacle partitioned into first and second chambers.
31. A package according to claim 28 further comprising a tube comprising said first or said second composition and an inner tube comprising the other of said first or second composition.
32. A package according to claim 28, wherein the package is squeezable to expel said first and second compositions.
33. A process to prepare an acne treatment kit comprising inserting a first composition which is anhydrous and comprises a component that in the presence of water generates heat into a first chamber of a multi-chambered package and inserting a second composition which comprises an aqueous carrier into a second chamber of said package, at least one of said compositions comprising an acne active ingredient, and providing means for combining said compositions on, or prior to application to, the skin.
34. A process of dispensing an acne treatment onto the skin comprising the application to the skin of a first composition which is anhydrous and comprises a component that in the presence of water generates heat, and a second composition which comprises an aqueous carrier, at least one of said compositions comprising an acne active ingredient and mixing said compositions to generate heat on the skin.
35. A method for reducing the oily feel on the skin of an anhydrous composition including a hydrocarbon carrier comprising the incorporation of a surfactant in said composition.
36. A method according to claim 5, wherein the keratolytic agent is salicylic acid.
37. A composition according to claim 23, wherein the hydrocarbon comprises a mineral oil.
US12/811,705 2008-01-04 2008-12-24 Skincare Treatment Abandoned US20110121033A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0800145.5 2008-01-04
GBGB0800145.5A GB0800145D0 (en) 2008-01-04 2008-01-04 Skincare treatment
PCT/GB2008/004283 WO2009087354A2 (en) 2008-01-04 2008-12-24 Skincare treatment

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/004283 A-371-Of-International WO2009087354A2 (en) 2008-01-04 2008-12-24 Skincare treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/590,618 Division US11110044B2 (en) 2008-01-04 2017-05-09 Skincare treatment

Publications (1)

Publication Number Publication Date
US20110121033A1 true US20110121033A1 (en) 2011-05-26

Family

ID=39111155

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/811,705 Abandoned US20110121033A1 (en) 2008-01-04 2008-12-24 Skincare Treatment
US15/590,618 Expired - Fee Related US11110044B2 (en) 2008-01-04 2017-05-09 Skincare treatment

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/590,618 Expired - Fee Related US11110044B2 (en) 2008-01-04 2017-05-09 Skincare treatment

Country Status (6)

Country Link
US (2) US20110121033A1 (en)
EP (1) EP2240184B1 (en)
AU (1) AU2008346288B2 (en)
GB (1) GB0800145D0 (en)
RU (1) RU2010132650A (en)
WO (1) WO2009087354A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110138678A1 (en) * 2008-01-31 2011-06-16 Colin Smith Insect trap
US20140147504A1 (en) * 2012-11-27 2014-05-29 Hovione International Ltd. Tetracycline topical formulations, preparation and uses thereof
CN105324474A (en) * 2013-06-18 2016-02-10 葛廷解决方案有限责任公司 Compositions for removing stains and deposits
US20200123338A1 (en) * 2017-07-11 2020-04-23 Technion Research & Development Foundation Limited Liquid-retaining elastomeric compositions, process of preparation and uses thereof
US11596641B2 (en) * 2020-03-24 2023-03-07 Hovione Scientia Limited Methods and compositions for treating meibomian gland dysfunction

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0800145D0 (en) * 2008-01-04 2008-02-13 Reckitt Benckiser Uk Ltd Skincare treatment
JP1665824S (en) 2019-08-21 2020-08-11
WO2021042127A1 (en) 2019-08-30 2021-03-04 The Procter & Gamble Company A packaged hair care composition
EP4237097A1 (en) 2020-10-27 2023-09-06 The Procter & Gamble Company Warming conditioner
USD1006632S1 (en) 2020-12-11 2023-12-05 The Procter & Gamble Company Container for hair care products
USD1012718S1 (en) 2020-12-21 2024-01-30 The Procter & Gamble Company Container for hair care product

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663716A (en) * 1970-06-22 1972-05-16 Miles Lab Method of treating acne with benzyl alcohol
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
US5221534A (en) * 1989-04-26 1993-06-22 Pennzoil Products Company Health and beauty aid compositions
WO2002060408A1 (en) * 2001-02-01 2002-08-08 The Procter & Gamble Company Anhydrous cosmetic compositions
US20040208902A1 (en) * 2003-04-18 2004-10-21 Gupta Shyam K. Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions
WO2005030160A1 (en) * 2003-09-29 2005-04-07 H.S.A. HAIR STYLING APPLICATIONS S.p.a. A cosmetic product comprising a fruit component

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4379143A (en) * 1980-12-05 1983-04-05 Pq Corporation Topical liquid or ointment
EP0639068A1 (en) * 1992-05-05 1995-02-22 The Procter & Gamble Company Acne treating composition
US5955067A (en) * 1996-07-23 1999-09-21 Oge; Eray Potassium-containing composition useful in the treatment of acne, psoriasis and seborrhea
JP4316177B2 (en) * 1999-07-08 2009-08-19 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド Exothermic local feeder
JP2001187741A (en) * 1999-12-28 2001-07-10 Lion Corp External pharmaceutical composition for skin
DE10237738A1 (en) * 2002-08-17 2004-02-26 Beiersdorf Ag Self-heating composition, especially for skin cleansing or care, comprises two components stored in a package with one or two exit openings
GB0800145D0 (en) * 2008-01-04 2008-02-13 Reckitt Benckiser Uk Ltd Skincare treatment

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663716A (en) * 1970-06-22 1972-05-16 Miles Lab Method of treating acne with benzyl alcohol
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
US5221534A (en) * 1989-04-26 1993-06-22 Pennzoil Products Company Health and beauty aid compositions
WO2002060408A1 (en) * 2001-02-01 2002-08-08 The Procter & Gamble Company Anhydrous cosmetic compositions
US20040208902A1 (en) * 2003-04-18 2004-10-21 Gupta Shyam K. Controlled-release nano-diffusion delivery systems for cosmetic and pharmaceutical compositions
WO2005030160A1 (en) * 2003-09-29 2005-04-07 H.S.A. HAIR STYLING APPLICATIONS S.p.a. A cosmetic product comprising a fruit component

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Kubo et al., Journal of Natural Products. Vol. 57, No. 1, January 1994: pp. 9-17. *
Togashi et al. Molecules 2007, 12, 139-148. *
WO 2002/060408 ("Uchid") as evidenced by US 3,663,716 ("Stolar") as applied to claims 22-25, 27 and 37, in further view of US 4,822,604 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8959831B2 (en) * 2008-01-31 2015-02-24 Colin Smith Insect trap
US20110138678A1 (en) * 2008-01-31 2011-06-16 Colin Smith Insect trap
US20170182071A1 (en) * 2012-11-27 2017-06-29 Hovione International Ltd. Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
US20140147504A1 (en) * 2012-11-27 2014-05-29 Hovione International Ltd. Tetracycline topical formulations, preparation and uses thereof
CN104902875A (en) * 2012-11-27 2015-09-09 好利安科学有限公司 Tetracycline topical formulations, preparation and uses thereof
JP2016500095A (en) * 2012-11-27 2016-01-07 ホビオネ サイエンティア リミテッド Tetracycline topical formulation, its preparation and use
US10213443B2 (en) * 2012-11-27 2019-02-26 Hovione Scientia Limited Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
US9592246B2 (en) * 2012-11-27 2017-03-14 Hovione International Ltd. Tetracycline topical formulations, preparation and uses thereof
US20160137955A1 (en) * 2013-06-18 2016-05-19 Geting Solutions Gmbh Agent for removing stains and deposits
US10047322B2 (en) * 2013-06-18 2018-08-14 Buck Service Gmbh Agent for removing stains and deposits comprising an alkylene styrene copolymer
CN105324474A (en) * 2013-06-18 2016-02-10 葛廷解决方案有限责任公司 Compositions for removing stains and deposits
CN105324474B (en) * 2013-06-18 2019-09-13 巴克服务有限责任公司 Composition for removing stains and deposits
US20200123338A1 (en) * 2017-07-11 2020-04-23 Technion Research & Development Foundation Limited Liquid-retaining elastomeric compositions, process of preparation and uses thereof
US11596641B2 (en) * 2020-03-24 2023-03-07 Hovione Scientia Limited Methods and compositions for treating meibomian gland dysfunction

Also Published As

Publication number Publication date
EP2240184B1 (en) 2017-03-08
AU2008346288A1 (en) 2009-07-16
AU2008346288B2 (en) 2015-03-26
US11110044B2 (en) 2021-09-07
EP2240184A2 (en) 2010-10-20
US20170246093A1 (en) 2017-08-31
RU2010132650A (en) 2012-02-10
WO2009087354A2 (en) 2009-07-16
WO2009087354A3 (en) 2009-11-26
GB0800145D0 (en) 2008-02-13

Similar Documents

Publication Publication Date Title
US11110044B2 (en) Skincare treatment
ES2197457T3 (en) CLEANING COMPOSITION WITH CLEANING BASE AND ADVANTAGE BASE THAT ARE DISPERSED SEPARATELY IN WHICH THE ADVANTAGE BASE ALSO CONTAINS TENSIOACTIVE.
RU2695615C1 (en) Foaming composition containing at least one surfactant of glycinate type
AU2015238222B2 (en) Rinse-off chemical mousse containing benzoyl peroxide
WO2010069995A1 (en) Silicone-free transparent two-phase composition
US20140366907A1 (en) Composition for the oxidation dyeing of keratin fibres, comprising particular fatty alcohols, a liquid fatty substance and a cationic polymer
BRPI0713182A2 (en) adaptalene uses of one of its pharmaceutically acceptable salts, kit and product
JP2011136992A (en) Cosmetic cleansing composition containing jasmonic acid derivative and surfactant
FR2993177A1 (en) BIPHASIC COMPOSITION CONTAINING ALKYLPOLYGLUCOSIDE AND A FUSION POINT ESTER LESS THAN 10 ° C
BR102016022176A2 (en) compositions and methods for treating blackheads
ES2280629T3 (en) DAPSONE TOPICO FOR THE TREATMENT OF ACNE.
BR112017009270B1 (en) COMPOSITIONS FOR PERSONAL CARE, SKIN CLEANING METHOD AND KIT
ES2990101T3 (en) Personal care compositions and methods comprising trans-1-chloro-3,3,3-trifluoropropene and trans-1,3,3,3-tetrafluoropropene
CN106456472A (en) Composition with optical effects
JP2004285047A (en) Transparent two-phase composition for topical application
EP2046273A2 (en) Rinse-off therapeutic agents for treating skin
US20110059035A1 (en) Compositions based on polymer/hydrogen peroxide complexes and uses thereof
ES2282824T3 (en) BIFASSIC COMPOSITION AND ITS USE IN COSMETICS.
US20200146969A1 (en) Dead sea salts cosmetic compositions
CN109875906A (en) Preservative Enhancer
CN104869979A (en) Cosmetic compositions, cosmetic methods for cleansing keratin, and uses thereof
AU2015202797A1 (en) Skincare treatment
BRPI1007164B1 (en) a topical composition comprising a depilatory agent, an agent for preventing or reducing hair growth and another for preventing or reducing hair interlocking, a hair removal method, and a method for preventing or reducing hair growth
JP6770339B2 (en) Miconazole nitrate-containing composition
WO2018114800A1 (en) Composition comprising an amps polymer, montmorillonite, silica and kaolin

Legal Events

Date Code Title Description
AS Assignment

Owner name: RECKITT BENCKISER (UK) LIMITED, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HORNE, REBECCA;KELLY, DIANE;KIRCHHOFFER, LAURENT;AND OTHERS;SIGNING DATES FROM 20100827 TO 20101126;REEL/FRAME:025496/0867

AS Assignment

Owner name: RECKITT & COLMAN (OVERSEAS) LIMITED, UNITED KINGDO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RECKITT BENCKISER (UK) LIMITED;REEL/FRAME:026215/0297

Effective date: 20110419

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION